These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16269938)
1. Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues. Ben-Ami R; Paran D; Herishanu Y; Elkayam O; Shopin L Blood Coagul Fibrinolysis; 2005 Nov; 16(8):619. PubMed ID: 16269938 [No Abstract] [Full Text] [Related]
2. [Adverse effects of intravenous human polyvalent immunoglobulins]. Chapuis C; Guy N; Besson G Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580 [No Abstract] [Full Text] [Related]
3. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome. Steinberger B; Coleman TA Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662 [No Abstract] [Full Text] [Related]
4. The successful use of i.v. gammaglobulin for Guillain-Barré syndrome following gold therapy in an RA patient. Tektonidou MG; Skopouli FN Clin Exp Rheumatol; 2003; 21(3):404-5. PubMed ID: 12846068 [No Abstract] [Full Text] [Related]
5. [Intravenous immunoglobulin therapy in neuroimmunological disorders]. Komoly S Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371 [No Abstract] [Full Text] [Related]
6. Venous and arterial thrombosis following administration of intravenous immunoglobulins. Paran D; Herishanu Y; Elkayam O; Shopin L; Ben-Ami R Blood Coagul Fibrinolysis; 2005 Jul; 16(5):313-8. PubMed ID: 15970713 [TBL] [Abstract][Full Text] [Related]
16. Effect of methylprednisolone in patients with Guillain-Barré syndrome. Susuki K; Yuki N Lancet; 2004 Apr; 363(9416):1236-7; author reply 1237-8. PubMed ID: 15081664 [No Abstract] [Full Text] [Related]
17. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis. Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414 [TBL] [Abstract][Full Text] [Related]